Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of New York, Vireo's performance in the Concentrates category has been noteworthy, despite not being in the top 30 brands in January 2026. By February, Vireo entered the rankings at 39th place and showed a gradual improvement by advancing to 38th by April. This upward trend indicates a positive trajectory, suggesting that Vireo is gaining traction in the New York market. The sales figures also reflect this improvement, with a consistent increase from February through April. This growth in sales and rankings highlights Vireo's potential to further enhance its market position in the coming months.
While Vireo's progress in New York is commendable, the absence of rankings in January 2026 suggests that the brand faced initial challenges in breaking into the top 30. This could be indicative of a competitive market environment or a late entry into the category. However, the subsequent positive movement in both rankings and sales suggests that Vireo is effectively addressing these challenges. The brand's ability to climb the ranks in a relatively short period is a promising sign, and it will be interesting to observe whether this momentum continues in the subsequent months. For more insights on the New York market, visit the New York market page.
Competitive Landscape
In the competitive landscape of the New York concentrates market, Vireo has shown a gradual improvement in its ranking and sales over the first four months of 2026. While it did not rank in January, Vireo climbed to 39th place in February, 41st in March, and improved to 38th in April. This upward trend in rank is mirrored by a consistent increase in sales, indicating a positive trajectory for the brand. In contrast, Veterans Choice Creations (VCC) started strong in January and February but did not maintain a top 20 position in March and April, suggesting a potential decline. High Peaks also showed fluctuating ranks, initially close to Vireo but dropping out of the top 20 by April. Meanwhile, Hepworth consistently outperformed Vireo, maintaining a strong presence in the top 31, although its sales showed a decline in April. High Falls Canna New York demonstrated a stable and strong performance, maintaining a higher rank than Vireo throughout the period. Vireo's steady rise in both rank and sales suggests a growing market presence, but it faces significant competition from brands like Hepworth and High Falls Canna New York, which continue to lead in sales and rank.

Notable Products
In April 2026, the top-performing product for Vireo was the Sativa RSO Syringe (1g) in the Concentrates category, maintaining its consistent first-place rank from January through April, with sales reaching 173 units. The Hybrid RSO Syringe (1g) also held steady at the second position, matching its previous month's sales of 94 units. Interestingly, the Indica RSO Syringe (1g) climbed to the second rank from an unranked position in March, showing significant sales growth. The CBD/THC 1:1 Green Balm (50mg CBD, 50mg THC, 1.5oz) in the Topical category improved its ranking to third place, a notable rise from fourth in March, with sales increasing to 36 units. Meanwhile, the CBD/THC 1:19 Red Balm (5mg CBD, 95mg THC, 1.5oz) dropped to fourth place, experiencing a decrease in sales to 30 units.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







